Lucid Diagnostics Depreciation & Amortization Growth & History (LUCD)
Lucid Diagnostics's depreciation and amortization was $872,000 for fiscal 2025.
View full Lucid Diagnostics company overviewLucid Diagnostics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $872,000 | −$295,000 | −25.28% |
| 2024 | 2024-12-31 | $1.2M | −$1.3M | −53.30% |
| 2023 | 2023-12-31 | $2.5M | $563,000 | +29.08% |
| 2022 | 2022-12-31 | $1.9M | $1.9M | +48300.00% |
| 2021 | 2021-12-31 | $4,000 | — | — |
Lucid Diagnostics quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $224,000 | $2,000 | +0.90% |
| Q1 2026 | 2026-03-31 | $222,000 | $1,000 | +0.45% |
| Q4 2025 | 2025-12-31 | $209,000 | — | — |
| Q3 2025 | 2025-09-30 | $220,000 | $5,000 | +2.33% |
| Q2 2025 | 2025-06-30 | $222,000 | −$7,000 | −3.06% |
| Q1 2025 | 2025-03-31 | $221,000 | −$280,000 | −55.89% |
| Q3 2024 | 2024-09-30 | $215,000 | −$410,000 | −65.60% |
| Q2 2024 | 2024-06-30 | $229,000 | −$404,000 | −63.82% |
| Q1 2024 | 2024-03-31 | $501,000 | −$111,000 | −18.14% |
| Q3 2023 | 2023-09-30 | $625,000 | $32,000 | +5.40% |
| Q2 2023 | 2023-06-30 | $633,000 | −$71,000 | −10.09% |
| Q1 2023 | 2023-03-31 | $612,000 | $588,000 | +2450.00% |
| Q3 2022 | 2022-09-30 | $593,000 | $593,000 | — |
| Q2 2022 | 2022-06-30 | $704,000 | — | — |
| Q1 2022 | 2022-03-31 | $24,000 | $21,000 | +700.00% |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $3,000 | — | — |
Lucid Diagnostics depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Lucid Diagnostics's depreciation and amortization increased from $4,000 to $872,000, a change of $868,000. The latest reported quarter, Q2 2026, shows $224,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lucid Diagnostics source filings ↗